Vivanza Biosciences Ltd share price logo

Vivanza Biosciences Share Price

BSE: 530057

Small Cap

Healthcare Sector

₹2.16

-0.11

(-4.85%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Vivanza Biosciences Stock Performance

as on January 12, 2026 at 4:01 pm IST

  • Day's High

    ₹2.16
    ₹2.22

    2.78%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹1.9
    ₹3.69
    downward going graph

    12.04%

    Downside

    70.83%

    Upside

    downward going graph

Vivanza Biosciences share price movements today

Previous Close
₹2.27
Open
₹2.22
Volume
5,391.00
Upper Circuit
₹2.38
Lower Circuit
₹2.16
Day's Low - High
₹2.16 - ₹2.22
52 Week Low - High
₹1.9 - ₹3.69

Vivanza Biosciences Historical Returns

1 Month Return
+ 11.27 %
3 Month Return
+ 9.66 %
1 Year Return
-30.79 %
3 Year Return
-85.9 %
5 Year Return
-82.1 %

Vivanza Biosciences Fundamentals

as on January 12, 2026 at 4:01 pm IST

Market Cap

₹9.08 Cr

Return on Equity (ROE)

-16.02

PE Ratio (TTM)

-28.38

Return on capital employed (ROCE)

-3.87

Industry PE ratio

42.25

Beta (LTM)

0.23

P/B Ratio

1.97

Dividend Yield

0

PEG Ratio

283.75

Quarterly Earnings Growth YOY

2700

EPS (TTM)

-0.17

Sector

Pharmaceuticals

Book Value

0.99

Technical Analysis

Bearish

View Technical Analysis

Vivanza Biosciences Stock Valuation

as on January 12, 2026 at 4:01 pm IST

Vivanza Biosciences in the last 5 years

  • Overview

  • Trends

Lowest (-15423.93x)

December 21, 2022

Today (-28.38x)

January 9, 2026

Industry (42.25x)

January 9, 2026

Highest (884.71x)

July 19, 2023

LowHigh

Today’s Price to Earnings Ratio: -28.38x

Vivanza Biosciences Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Vivanza Biosciences with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Vivanza Biosciences Ltd image
Vivanza Biosciences Ltd
NA9.08-16.42%0.84-17
Aarey Drugs & Pharmaceuticals Ltd image
Aarey Drugs & Pharmaceuticals Ltd
NA196.6912%0.004473
Krebs Biochemicals & Industries Ltd image
Krebs Biochemicals & Industries Ltd
NA144.26-9.85%0.00-2743
Haleos Labs Limited image
Haleos Labs Limited
NA391.0624.02%0.6818344
Kimia Biosciences Ltd image
Kimia Biosciences Ltd
NA152.58-7.89%0.009118
See all

Vivanza Biosciences Share Price Target

Get share price movements and forecasts by analysts on Vivanza Biosciences.

Source: S&P Global Market Intelligence

Vivanza Biosciences Stock’s Investor Sentiment and Interest

Search interest for Vivanza Biosciences Ltd Stock has increased by 25% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:25% versus previous 30 day period

Vivanza Biosciences Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Sales
8.24
9.23
7.62
6.56
4.42
2.44
3
1.5
0.48
8.94
55.36
Other Income
0.12
0.01
0.05
0.02
-0.03
-
-
0.01
0.05
0.02
0.01
Total Income
8.36
9.24
7.67
6.58
4.39
2.44
3
1.51
0.53
8.96
55.37
Expenses
8.24
8.64
7.3
6.27
4.56
2.08
2.89
1.38
1.44
8.79
54.75
Operating Profit
-
0.59
0.32
0.29
-0.14
0.36
0.11
0.12
-0.96
0.15
0.61
Operating Profit Margin %
0%
6.39%
4.2%
4.42%
-3.17%
14.75%
3.67%
8%
-200%
1.68%
1.1%
Profit Before Interest, Tax and Depreciation
0.12
0.61
0.37
0.31
-0.16
0.36
0.11
0.13
-0.91
0.17
0.61
Interest
0.11
0.11
0.11
0.1
0.09
0.09
0.09
0.09
0.08
0.08
0.05
Depreciation
-
-
-
-
0.01
-
-
-
-
-
-
Profit Before Tax
0.01
0.5
0.26
0.21
-0.26
0.27
0.02
0.04
-0.99
0.09
0.56
Tax Paid
0.12
-
-
-
0.15
-
-
-
0.01
-
-
Profit After Tax
-0.1
0.49
0.26
0.21
-0.41
0.27
0.02
0.04
-1
0.09
0.56
Total Net profit including share of profit / Loss from associate company
-0.1
0.49
0.26
0.21
-0.41
0.27
0.02
0.04
-1
0.09
0.56
EPS
-0.26
0.12
0.07
0.05
-0.1
0.07
-
0.01
-0.25
0.02
0.14
Actual EPS
-0.26
0.12
0.07
0.05
-0.1
0.07
-
0.01
-0.25
0.02
0.14
Adjusted EPS
-0.26
0.12
0.07
0.05
-0.1
0.07
-
0.01
-0.25
0.02
0.14
Diluted EPS
-0.26
0.12
0.07
0.05
-0.1
0.07
-
0.01
-0.25
0.02
0.14

Vivanza Biosciences Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Sales
3.47
6.44
2.66
9.62
9.89
10.4
17.81
27.84
7.42
Other Income
0.05
-
-
0.57
0.51
0.83
0.48
0.05
0.06
Total Income
3.52
6.44
2.66
10.19
10.39
11.23
18.28
27.89
7.48
Expenses
3.79
5.85
2.68
9.96
9.79
10.48
17.14
26.77
7.79
Operating Profit
-0.32
0.59
-0.02
-0.34
0.1
-0.08
0.67
1.07
-0.37
Operating Profit Margin %
-9.22%
9.16%
-0.75%
-3.53%
1.01%
-0.77%
3.76%
3.84%
-4.99%
Profit Before Interest, Tax and Depreciation
-0.27
0.59
-0.02
0.23
0.6
0.75
1.14
1.12
-0.3
Interest
0.04
0.36
0.42
0.44
0.47
0.41
0.42
0.41
0.35
Depreciation
-
-
-
-
0.01
0.01
-
0.01
0.01
Profit Before Tax
-0.31
0.23
-0.44
-0.21
0.12
0.33
0.72
0.7
-0.66
Tax Paid
-
0.03
-
-
0.05
-
0.12
0.15
0.01
Profit After Tax
-0.31
0.21
-0.44
-0.21
0.08
0.33
0.6
0.55
-0.67
Total Net profit including share of profit / Loss from associate company
-0.31
0.21
-0.44
-0.21
0.08
0.33
0.6
0.55
-0.67
EPS
-0.78
0.51
-1.1
-0.51
0.19
0.83
0.14
0.14
-0.17
Actual EPS
-0.78
0.51
-1.1
-0.51
0.19
0.83
0.14
0.14
-0.17
Adjusted EPS
-0.01
0.01
-0.11
-0.05
0
0.08
0.14
0.14
-0.17
Diluted EPS
-0.78
0.51
-1.1
-0.51
0.19
0.83
0.14
0.14
-0.17

Vivanza Biosciences Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
-
-2.07
-0.09
0.86
2.98
-3.08
2.47
-0.95
2.04
-2.5
Cash Flow from Investing Activities
-
-
-
-
-
-0.02
-
-
-0.04
-0.01
Cash Flow from Financing Activities
-
0.4
-0.55
-0.89
-2.76
2.8
-2.47
1.03
-1.98
2.46
Net Cash Flow
-
0.23
-0.64
-0.03
0.22
-0.3
-0.01
0.09
0.03
-0.05

Vivanza Biosciences Stock Shareholding Pattern

Numbers in percentages

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Promoters
47.8%
47.8%
47.29%
44.9%
43.24%
40.05%
39.86%
20.02%
20.02%
20.02%
20.02%
Public
52.2%
52.2%
52.71%
55.1%
56.76%
59.95%
60.13%
79.98%
79.98%
79.98%
79.98%
Total Outstanding Shares
4,00,00,000
4,00,00,000
4,00,00,000
4,00,00,000
4,00,00,000
4,00,00,000
4,00,00,000
4,00,00,000
4,00,00,000
4,00,00,000
4,00,00,000
Total Shareholders
4,872
4,867
5,039
5,937
6,992
16,941
16,701
20,635
20,833
20,458
20,170

Vivanza Biosciences Corporate Actions

View detailed summary of the earnings and dividend history of Vivanza Biosciences.

  • Vivanza Biosciences Ltd Earnings Results

    Vivanza Biosciences Ltd’s net profit jumped 2700% since last year same period to ₹0.56Cr in the Q2 2025-2026. On a quarterly growth basis, Vivanza Biosciences Ltd has generated 522.22% jump in its net profits since last 3-months.

    Read More about Earnings Results

Insights on Vivanza Biosciences Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 3 quarters, 0.53 Cr → 55.37 Cr (in ₹), with an average increase of 89.0% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, Vivanza Biosci. stock has moved up by 3.7%

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 3 quarters, -1.0 Cr → 0.56 Cr (in ₹), with an average increase of 647.5% per quarter

  • imgNO EFFECT

    Retail Holding Unchanged

    img

    Retail Investor holdings remained unchanged at 79.98% of holdings in Sep 2025 quarter

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 20.02% of holdings in Sep 2025 quarter

About Vivanza Biosciences Ltd

Ivee Injectaa, a public limited company incorporated in March 1982 is engaged in large-volume parenteral drug manufacturing with an installed capacity of 18 lac pa in Sabalpur, Gujarat. Recently, it has completed an expansion and diversification program to increase the production to 54 lac pa with an additional small-volume parenteral manufacturing capacity of 294 lac pa. To fund the expansion, a public issue of 2170000 equity shares of Rs 10 each was released, aggregating Rs 217 lac. As one of the few companies with facilities for both glass and plastic containers, Ivee Injectaa was awarded a rate contract from the Government of Gujarat to supply its products for one year. Amidst the difficult business conditions in 19992000 due to recessionary trends, the company continues to strive for overall improvement in working.

Revenue: ₹55.36Cr as on September 2025 (Q2 FY26)
Net Profit: ₹0.56Cr as on September 2025 (Q2 FY26)
OrganisationVivanza Biosciences Ltd
IndustryPharmaceuticals
E-voting on sharesClick here to vote

FAQs

What is Vivanza Biosciences share price today?

Vivanza Biosciences share price today stands at ₹2.16 as on at the close of the market. Vivanza Biosciences share today touched a day high of ₹2.22 and a low of ₹2.16.

What is the 52 week high and 52 week low range for Vivanza Biosciences share?

Vivanza Biosciences touched a 52 week high of ₹3.69 and a 52 week low of ₹1.9. Vivanza Biosciences share price today i.e. is closed at ₹2.16, which is -41.46% down from its 52 week high and 13.68% up from its 52 week low.

What is Vivanza Biosciences's market capitalisation today?

Vivanza Biosciences market capitalisation is ₹9.08 Cr as on .

How to buy Vivanza Biosciences shares?

To buy Vivanza Biosciences shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for 530057 or Vivanza Biosciences Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Vivanza Biosciences shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Vivanza Biosciences trading volume today?

Vivanza Biosciences trading volume is 5,391.00 as on . This means that 5,391.00 shares of Vivanza Biosciences were bought and sold on the stock market during today's trading session.